SCHEMBL4167783

SCHEMBL4167783

CC(C)c1cc2cc(Cl)cc(Cc3ccc(C(=O)Nc4ccc(CN5CCC(O)CC5)cc4)o3)c2o1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 8/20 0.52
SMN1; SMN2 Q16637 5/20 0.43
KMT2A Q03164 5/20 0.43
ALDH1A1 P00352 3/20 0.43
MEN1 O00255 3/20 0.43
KDM4E B2RXH2 2/20 0.43
MAPT P10636 2/20 0.43
HTT P42858 2/20 0.43
HPGD P15428 2/20 0.43
MAPK1 P28482 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
PRKD3 O94806 1/20 0.43
PRKD1 Q15139 1/20 0.43
PRKD2 Q9BZL6 1/20 0.43
LMNA P02545 2/20 0.42
POLB P06746 1/20 0.42
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
TP53 P04637 1/20 0.40
PTGER3 P43115 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4168845 0.99 PTGER1 (0.51) PTGER1SMN1; SMN2KMT2AALDH1A1MEN1
SCHEMBL4167685 0.92 PTGER1 (0.55) PTGER1SMN1; SMN2KMT2AALDH1A1MEN1
SCHEMBL4157725 0.91 PTGER1 (0.54) PTGER1SMN1; SMN2KMT2AALDH1A1MEN1
Hydrochloric Acid SCHEMBL4162562 0.90 PTGER1 (0.53) PTGER1SMN1; SMN2KMT2AALDH1A1MEN1
SCHEMBL4162628 0.84 PTGER1 (0.55) PTGER1SMN1; SMN2KMT2AALDH1A1MEN1
SCHEMBL4159944 0.83 PTGER1 (0.75) PTGER1PTGER3
Hydrochloric Acid SCHEMBL4164987 0.82 PTGER1 (0.74) PTGER1PTGER3
SCHEMBL4160757 0.82 PTGER1 (0.53) PTGER1SMN1; SMN2KMT2AALDH1A1MEN1
SCHEMBL4157559 0.81 PTGER1 (0.56) PTGER1SMN1; SMN2KMT2AALDH1A1MEN1
Hydrochloric Acid SCHEMBL4161533 0.80 PTGER1 (0.55) PTGER1SMN1; SMN2KMT2AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099169-A1 Benzofuran Compounds As EP1 Receptor Antagonists GLAXO GROUP LIMITED (GB) 2009-04-16 US claimed
US-20090099169-A1 Benzofuran Compounds As EP1 Receptor Antagonists GLAXO GROUP LIMITED (GB) 2009-04-16 US disclosed
US-20090099169-A1 Benzofuran Compounds As EP1 Receptor Antagonists GLAXO GROUP LIMITED (GB) 2009-04-16 US disclosed
WO-2007113289-A1 BENZOFURAN COMPOUNDS AS EP1 RECEPTOR ANTAGONISTS GLAXO GROUP LIMITED (GB) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099169-A1 Benzofuran Compounds As EP1 Receptor Antagonists PTGER1, PTGER2, PTGER3 PTGER1 1/4885SMN1; SMN2 2462/4885KMT2A 1887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.